According to Terns Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.29. In 2022 the company made an earnings per share (EPS) of -$1.83 an increase over its 2021 EPS that were of -$2.34.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.29 | -29.51% |
2022 | -$1.83 | -21.79% |
2021 | -$2.34 | 91.38% |
2020 | -$1.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 68.99% | ๐บ๐ธ USA |